| LAZERTINIB 
| LAZERTINIB | ATC L01EB09
ANTINEOPLASTIC EGFR KINASE INHIBITOR TREATMENT OF ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) | ORAL | Tmax 3 HOUR VD 2680 LITER PPB 99.2 PERCENT Cl 36.4 LITER / HOUR HT 88.8 HOUR | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PDB 7UKV (WILD TYPE EGFR IN COMPLEX WITH LAZERTINIB (YH25448)) LIGAND CODE = ZRT (link to the list of PDB complexes) Download experimental 3D coordinates of ZRT with added hydrogens | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |